3 Matching Annotations
  1. Last 7 days
    1. Molecular and clinicopathologic features of gliomas harboring NTRK fusions

      [Paper-level Aggregated] PMCID: PMC7362646

      Evidence Type(s): Oncogenic, Prognostic

      Justification: Oncogenic: The IDH1 p.R132H mutation is mentioned as a significant alteration in adult gliomas, indicating its role in tumorigenesis. Prognostic: The presence of the IDH1 p.R132H mutation correlates with specific histological grades and patient age cohorts, suggesting it may have implications for patient outcomes.

      Gene→Variant (gene-first): IDH1(3417):p.R132H

      Genes: IDH1(3417)

      Variants: p.R132H

    2. NTRK-fused gliomas in our cohort demonstrated concurrent aberrations involving CDKN2A/2B, TERT promoter, TP53, PTEN, EGFR, ATRX, RB1, IDH1, polysomy 7, ROS1, PIK3CA, NF1, and MDM4. The frequency of these genetic aberrati

      [Paragraph-level] PMCID: PMC7362646 Section: RESULTS PassageIndex: 11

      Evidence Type(s): Oncogenic

      Justification: Oncogenic: The passage discusses the IDH1 p.R132H mutation as part of the genetic aberrations detected in gliomas, indicating its contribution to tumor development or progression in the context of high-grade gliomas.

      Gene→Variant (gene-first): 3417:p.R132H

      Genes: 3417

      Variants: p.R132H

    3. NTRK-fused gliomas in our cohort demonstrated concurrent aberrations involving CDKN2A/2B, TERT promoter, TP53, PTEN, EGFR, ATRX, RB1, IDH1, polysomy 7, ROS1, PIK3CA, NF1, and MDM4. The frequency of these genetic aberrati

      [Paragraph-level] PMCID: PMC7362646 Section: RESULTS PassageIndex: 11

      Evidence Type(s): Oncogenic

      Justification: Oncogenic: The passage discusses the IDH1 p.R132H mutation as part of the genetic aberrations detected in gliomas, indicating its contribution to tumor development or progression in the context of high-grade gliomas.

      Gene→Variant (gene-first): 3417:p.R132H

      Genes: 3417

      Variants: p.R132H